Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
878.7 DKK | -1.41% | +0.85% | +25.87% |
Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Apr. 24 | Sector Update: Health Care | MT |
Sales 2024 * | 287B 41.27B | Sales 2025 * | 346B 49.64B | Capitalization | 3,920B 563B |
---|---|---|---|---|---|
Net income 2024 * | 104B 14.87B | Net income 2025 * | 125B 17.92B | EV / Sales 2024 * | 13.7 x |
Net Debt 2024 * | 23.85B 3.43B | Net cash position 2025 * | 348M 50.02M | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
38
x | P/E ratio 2025 * |
31.3
x | Employees | 63,845 |
Yield 2024 * |
1.34% | Yield 2025 * |
1.6% | Free-Float | 70.47% |
Latest transcript on Novo Nordisk A/S
1 day | -1.41% | ||
1 week | +0.85% | ||
Current month | -0.30% | ||
1 month | -0.96% | ||
3 months | +21.20% | ||
6 months | +28.86% | ||
Current year | +25.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 90-12-31 | |
Director of Finance/CFO | 53 | 98-12-31 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 63 | 15-03-18 |
Helge Lund
CHM | Chairman | 61 | 17-03-22 |
Martin MacKay
BRD | Director/Board Member | 68 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
21.31% | 192 M€ | +12.40% | ||
10.45% | 5 M€ | +7.56% | ||
5.40% | 18 M€ | +3.04% | - | |
4.67% | 88 M€ | +10.37% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 878.7 | -1.41% | 1,877,505 |
24-04-23 | 891.3 | +1.83% | 1,866,811 |
24-04-22 | 875.3 | +1.05% | 2,031,675 |
24-04-19 | 866.2 | +0.41% | 1,938,339 |
24-04-18 | 862.7 | -0.99% | 2,297,378 |
Delayed Quote Nasdaq Copenhagen, April 24, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.87% | 562B | |
+25.61% | 660B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B | |
-5.21% | 146B |
- Stock Market
- Equities
- NOVO B Stock